1
|
Brunault P, Ingrand I, Solinas M, Dugast E, Pérault-Pochat MC, Ingrand P, Vanderkam P, Lafay-Chebassier C. Smokers with higher positive or negative urgency have lower rates of smoking cessation success 12 months after a quit attempt. Sci Rep 2024; 14:12321. [PMID: 38811767 PMCID: PMC11137130 DOI: 10.1038/s41598-024-62972-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2023] [Accepted: 05/23/2024] [Indexed: 05/31/2024] Open
Abstract
Impulsivity dimensions have been shown to be associated with smoking status and tobacco use disorder severity. However, it is important to determine the specific impulsivity traits associated with smoking relapse. This study aimed at investigating the associations between impulsivity traits and smoking cessation success among adult smokers at 12 months after a quit attempt. Participants were 68 adult smokers enrolled in a 3-month course of simvastatine or placebo associated with behavioral cessation support, with a 9-month follow-up (ADDICSTATINE study). They were classified in 3 groups according to smoking status: abstinent, reduction ≥ 50%baseline or reduction < 50%baseline at 3 and 12 months. Impulsivity traits were assessed using the UPPS-P-scale. At 12 months, abstainers and participants who reduced smoking by 50% or more had significantly lower scores in negative and positive urgency compared to participants who reduced smoking by less than 50% (p = 0.011 and 0.0059). These urgency traits scores at 12 months were significantly and negatively correlated with smoking reduction at 12 months (p = 0.017 and 0.0012). These impulsivity traits were also associated with the smoking cessation success at 3 months. Patients who were abstinent at 3 months had also lower negative and positive urgency (p = 0.017 and 0.0039). Smoking cessation success at 3 and 12 months were not associated with the other impulsivity traits, sensation seeking, lack of premeditation or perseverance. Our findings suggest that positive and negative urgency are associated with smoking cessation success. Proposing better tailored-based-treatment targeting these impulsivity traits in combination with conventional treatment may help improving smoking treatment success.
Collapse
Affiliation(s)
- Paul Brunault
- CHRU de Tours, Service d'Addictologie Universitaire, Équipe de Liaison et de Soins en Addictologie, Tours, France
- UMR 1253, iBrain, Université de Tours, Inserm, Tours, France
- Université de Tours, QualiPsy, EE 1901, Tours, France
| | - Isabelle Ingrand
- Registre Des Cancers Poitou-Charentes, Université de Poitiers, Poitiers, France
| | - Marcello Solinas
- INSERM U-1084, Laboratoire de Neurosciences Expérimentales et Cliniques, Université de Poitiers, Poitiers, France
- Unité de Recherche Clinique Pierre Deniker, Centre Hospitalier Henri Laborit, Poitiers, France
| | - Emilie Dugast
- INSERM U-1084, Laboratoire de Neurosciences Expérimentales et Cliniques, Université de Poitiers, Poitiers, France
- INSERM, Centre d'Investigation Clinique CIC 1402, Université de Poitiers, CHU Poitiers, Poitiers, France
| | - Marie-Christine Pérault-Pochat
- INSERM U-1084, Laboratoire de Neurosciences Expérimentales et Cliniques, Université de Poitiers, Poitiers, France
- INSERM, Centre d'Investigation Clinique CIC 1402, Université de Poitiers, CHU Poitiers, Poitiers, France
- Service de Pharmacologie Clinique, CHU Poitiers, Poitiers, France
| | - Pierre Ingrand
- Registre Des Cancers Poitou-Charentes, Université de Poitiers, Poitiers, France
- INSERM, Centre d'Investigation Clinique CIC 1402, Université de Poitiers, CHU Poitiers, Poitiers, France
| | - Paul Vanderkam
- INSERM U-1084, Laboratoire de Neurosciences Expérimentales et Cliniques, Université de Poitiers, Poitiers, France
- Département de Médecine Générale, Université de Bordeaux, Bordeaux, France
| | - Claire Lafay-Chebassier
- INSERM U-1084, Laboratoire de Neurosciences Expérimentales et Cliniques, Université de Poitiers, Poitiers, France.
- INSERM, Centre d'Investigation Clinique CIC 1402, Université de Poitiers, CHU Poitiers, Poitiers, France.
- Service de Pharmacologie Clinique, CHU Poitiers, Poitiers, France.
- Centre Hospitalier Universitaire de Poitiers, 2 rue de la Milétrie - CS 90577, 86021, Poitiers Cedex, France.
| |
Collapse
|
2
|
Sun H, Zhang H, Cai H, Yuan W, Wang F, Jiang Y, Gu X, Kang Z, Kang Y. Burden of Lung Cancer in China, 1990-2019: Findings from the Global Burden of Disease Study 2019. Cancer Control 2023; 30:10732748231198749. [PMID: 37632208 PMCID: PMC10467238 DOI: 10.1177/10732748231198749] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2023] [Revised: 07/19/2023] [Accepted: 08/15/2023] [Indexed: 08/27/2023] Open
Abstract
BACKGROUND Lung cancer is one of the most common malignant tumors in the world. It has become an increasingly important public health problem in China. In this study, we systematically assessed the lung cancer situation in China from 1990 to 2019 and provided an epidemiological knowledge base for the revision of health policies. The relevant data were extracted from the Global Burden of Disease (GBD) database. METHODS Based on GBD 2019 data, we evaluated the incidence, prevalence, and death rates of lung cancer in China and their change trends from 1990 to 2019, making comparisons by gender and age. RESULTS The age-standardized incidence and death rates (ASIR and ASDR, respectively) of lung cancer in China were higher than the average levels in Asia, Africa, Europe, and Oceania and also higher than those of neighboring Asian countries. Lung cancer rose from the seventh leading cause of death in 1990 to the fourth leading one in 2019, indicating that the disease burden of lung cancer is increasing. In 2019, the incidence, prevalence, and death rates of lung cancer were all higher in men than in women across all age groups. All three indices were lower in men and women <50 years old than in men and women >50 years. From 1990 to 2019, the ASIR, age-standardized prevalence rate (ASPR), and ASDR showed trends of increase (P < .05), and the rise in the ASPR (average annual percentage change [AAPC] = 1.9) was greater than those in the ASIR (AAPC = 1) and ASDR (AAPC = .8). CONCLUSIONS From 1990 to 2019, the incidence, prevalence, and death rates of lung cancer continued to increase in China. To reduce this burden, prevention and management of known risk factors should be promoted through national policies.
Collapse
Affiliation(s)
- Huixin Sun
- Institute of Cancer Prevention and Treatment, Harbin Medical University, Harbin City, People's Republic of China
| | - Haiyu Zhang
- Key Laboratory of Cardiovascular Disease Acousto-Optic Electromagnetic Diagnosis and Treatment in Heilongjiang Province, The First Affiliated Hospital, Harbin Medical University, Harbin City, People's Republic of China
| | - Huilong Cai
- Institute of Cancer Prevention and Treatment, Harbin Medical University, Harbin City, People's Republic of China
| | - Weiguang Yuan
- Institute of Cancer Prevention and Treatment, Harbin Medical University, Harbin City, People's Republic of China
| | - Fengjiao Wang
- Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin City, People's Republic of China
| | - Yang Jiang
- Department of Pathology, Harbin Medical University Cancer Hospital, Harbin City, People's Republic of China
| | - Xinyue Gu
- Colorectal Surgery, Harbin Medical University Cancer Hospital, Harbin City, People's Republic of China
| | - Ziman Kang
- Department of Radiology, Chengdu Second People's Hospital, Chengdu City, People's Republic of China
| | - Yue Kang
- Pelvic Floor Disease Center, Department of General Surgery, West China Hospital, Sichuan University, Chengdu City, People's Republic of China
| |
Collapse
|
3
|
Ding Y, He C, Zhao X, Xue S, Tang J. Adding predictive and diagnostic values of pulmonary ground-glass nodules on lung cancer via novel non-invasive tests. Front Med (Lausanne) 2022; 9:936595. [PMID: 36059824 PMCID: PMC9433577 DOI: 10.3389/fmed.2022.936595] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2022] [Accepted: 07/29/2022] [Indexed: 11/13/2022] Open
Abstract
Pulmonary ground-glass nodules (GGNs) are highly associated with lung cancer. Extensive studies using thin-section high-resolution CT images have been conducted to analyze characteristics of different types of GGNs in order to evaluate and determine the predictive and diagnostic values of GGNs on lung cancer. Accurate prediction of their malignancy and invasiveness is critical for developing individualized therapies and follow-up strategies for a better clinical outcome. Through reviewing the recent 5-year research on the association between pulmonary GGNs and lung cancer, we focused on the radiologic and pathological characteristics of different types of GGNs, pointed out the risk factors associated with malignancy, discussed recent genetic analysis and biomarker studies (including autoantibodies, cell-free miRNAs, cell-free DNA, and DNA methylation) for developing novel diagnostic tools. Based on current progress in this research area, we summarized a process from screening, diagnosis to follow-up of GGNs.
Collapse
Affiliation(s)
- Yizong Ding
- Department of Thoracic Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Chunming He
- Department of Thoracic Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Xiaojing Zhao
- Department of Thoracic Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Song Xue
- Department of Cardiovascular Surgery, Reiji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Jian Tang
- Department of Thoracic Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- *Correspondence: Jian Tang,
| |
Collapse
|